Overview of Dr. Welch
Dr. Mary Welch is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from McGaw Medical Center of Northwestern University and has been in practice 11 years. Dr. Welch accepts several types of health insurance, listed below. She is one of 484 doctors at New York-Presbyterian Hospital and one of 211 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. She has more than 30 publications and over 300 citings.
Office
710 West 168th Street
New York, NY 10032
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2007 - 2010
NYU Grossman School of MedicineInternship, Internal Medicine, 2006 - 2007
Northwestern University The Feinberg School of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2008 - 2026
CT State Medical License 2021 - 2025
NJ State Medical License 2019 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 26 citationsChronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.Eleonora F Spinazzi, Michael G Argenziano, Pavan S Upadhyayula, Matei A Banu, Justin A Neira
The Lancet. Oncology. 2022-11-01 - 29 citationsAlliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With SomaticMutations.Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner, Timothy J Kaufmann, A John Iafrate
Journal of Clinical Oncology. 2023-01-20 - 50 citationsIndividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Gliobl...Brian M. Alexander, Lorenzo Trippa, Sarah C. Gaffey, Isabel Arrillaga-Romany, Eudocia Q. Lee
JCO Precision Oncology. 2019-03-27
Insurance Accepted
- Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS PPO
GHI PPO
HIP of New York - Select PPOMagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
